| 1121/1644 | US=35 / Câncer Godley LA, Le Beau MM. Molecular foundations of AML pathogenesis and physiology: therapy-related AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 71-95. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; SINDROMES MIELODISPLASICAS; TERAPIA; AGENTE ALQUILANTE; EPIPODOFILOTOXINA; DISPLASIA; COMPLICACOES A LONGO PRAZO |
| 1122/1644 | US=35 / Câncer Steensma DP. Molecular foundations of AML pathogenesis and physiology: the DNA damage response, DNA repair, and AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 97-131. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; RESPOSTA DE DANO DO DNA; REPARO DE DNA; RECONHECIMENTO DOS DANOS DO DNA; REPARO POR EXCISAO DE BASE; REPARO POR EXCISAO DE NUCLEOTIDEOS; RECOMBINACAO HOMOLOGA; ANEMIA DE FANCONI; SINDROME DE BLOOM; FAMILIA RECQ HELICASES; SINDROMES HEREDITARIAS; ATAXIA-TELANGIECTASIA; SINDROME DE QUEBRA DE NIJMEGEN; SINDROME DE SECKEL; PROTEINA NIBRIN |
| 1123/1644 | US=35 / Câncer Mesa RA, Kaufmann SH. Molecular foundations of AML pathogenesis and physiology: altered apoptosis in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 133-61. ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; APOPTOSE; RESISTENCIA MEDICAMENTOSA; BCL-2; MCL-1; XIAP; MICROAMBIENTE DA MEDULA OSSEA; RAS; FLT3 |
| 1124/1644 | US=35 / Câncer Ross DD. Molecular foundations of AML pathogenesis and physiology: drug resistance transporters in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 163-73. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; TRANSPORTADORES DE RESISTENCIA DE DROGAS |
| 1125/1644 | US=35 / Câncer Grimwade D. Translating biology into clinical application: impact of cytogenetics on clinical outcome in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 177-92. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; BIOLOGIA; APLICACAO CLINICA; CITOGENETICA; REARRANJOS CROMOSSOMICOS CRIPTICOS; HIBRIDACAO IN SITU FLUORESCENTE; TRIAGEM MOLECULAR; ESTRATIFICACAO DE RISCO; DISSOMIA UNIPARENTAL ADQUIRIDA |
| 1126/1644 | US=35 / Câncer Sausville EA. Molecular therapeutics of AML: selected targeted approaches: emerging therapeutics for AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 231-46. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; EMERGENCIAS TERAPEUTICAS; NOVOS AGENTES; TERAPIA ALVO; VACINA; SINALIZACAO VEGF; ADAFOSTINA; TRITERPENOIDES |
| 1127/1644 | US=35 / Câncer Levis M. Molecular therapeutics of AML: FLT3: a prototype receptor tyrosine kinase target in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 247-61. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; QUINASE; FLT3; PROGNOSTICO; INIBIDORES; CELULAS TRONCO |
| 1128/1644 | US=35 / Câncer Lancet JE. Molecular therapeutics of AML: farnesyl transferase inhibitors in the therapy of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 263-74. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; FARNESILACAO; INIBIDORES DE FARNESITRANSFERASE; TRANSDUCAO DE SINAL |
| 1129/1644 | US=35 / Câncer Fandy T, Carraway H, Gore SD. Molecular therapeutics of AML: modulating gene expression as a therapeutic approach in the treatment of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 275-91. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; METILACAO DO DNA; AGENTE DEMETILANTE; 5-AZACITIDINA; INIBIDOR DA HISTONA DEACETILASE; PROMOTOR HIPER-METILACAO; HISTONA ACETILTRANSFERASE; HISTONA METILTRANSFERASE; DECITABINA |
| 1130/1644 | US=35 / Câncer Lin TL, Matsui W. Molecular therapeutics of AML: differentiation therapy in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 293-312. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; TERAPIA DIFERENCIADA; SINDROME MIELODISPLASICA; FATORES DE CRESCIMENTO; CICLO CELULAR; ACIDO RETINOICO; VITAMINA D; METILACAO DO DNA; BRIOSTATINA 1 |
| 1131/1644 | US=36 / Gastro Maitra A, Yeo CJ. Genetics and molecular biology of pancreatic and biliary cancers. In: Blumgart LH. Surgery of the biliary tract, and pancreas. 4th ed. Philadelphia: Elsevier Saunders, 2007. p. 136-52. (v.1) ISBN 978-1-4160-3256-8. CANCER DE PANCREAS E VIAS BILIARES; CANCER DE PANCREAS; CANCER DO TRATO BILIAR; MALIGNIDADES PANCREATOBILIARY; CANCER DE PANCREAS FAMILIAR |
| 1132/1644 | US=36 / Gastro Kelly CR, Wands JR. Molecular biology of liver carcinogenesis and hepatitis. In: Blumgart LH. Surgery of the biliary tract, and pancreas. 4th ed. Philadelphia: Elsevier Saunders, 2007. p. 153-63. (v.1) ISBN 978-1-4160-3256-8. BIOLOGIA MOLECULAR DE CARCINOGENESE DO FIGADO; BIOLOGIA MOLECULAR DE HEPATITE; VIRUS DA HEPATITE B; VIRUS DA HEPATITE C; P53 GENE SUPRESSOR DE TUMOR E AFLATOXINAS; TELOMERO ENCURTAMENTO; TRANSDUCAO DE VIAS DE SINALIZACAO |
| 1133/1644 | US=35 / Câncer Bolaños-Meade J, Jones RJ. Molecular therapeutics of AML: stem cell transplantation for AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 313-27. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; TRANSPLANTE DE CELULAS TRONCO; SINDROME MIELODISPLASICA; LEUCEMIA PROMIELOCITICA; TRANSPLANTE DE MEDULA OSSEA; DOENCA ENXERTO VERSUS HOSPEDEIRO |
| 1134/1644 | US=35 / Câncer Borrello I. Molecular therapeutics of AML: tumor vaccines in leukemia. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 329-41. (Contemporary Hematology) ISBN 978-1-58829-621-4. |
| 1135/1644 | US=35 / Câncer Gotlib J. Special challenges: dameshek smiles: molecular clues to the chronic myeloproliferative disorders unmasked. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 385-98. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; DOENCAS REUMATICAS CRONICAS; JAK2 V617F; POLICITEMIA VERA; TROMBOCITEMIA ESSENCIAL; MIELOFIBROSE IDIOPATICA; DOENCA MIELOPROLIFERATIVA |
| 1136/1644 | US=36-C / Biol/MOL Abbas AK, Lichtman AH, Pillai S. Introduction to the immune system: properties and overview of immune responses. In: Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. 6 ed. Philadelphia: Saunders, 2007. p. 3-17. ISBN 978-1-4160-3122-2. IMUNIDADE INATA E ADAPTATIVA; TIPOS DE RESPOSTAS IMUNES ADAPTATIVAS |
| 1137/1644 | US=36-C / Biol/MOL Abbas AK, Lichtman AH, Pillai S. Introduction to the immune system: innate immunity. In: Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. 6 ed. Philadelphia: Saunders, 2007. p. 19-46. ISBN 978-1-4160-3122-2. IMUNIDADE INATA; PAPEL DA IMUNIDADE INATA NO ESTIMULO; BARREIRAS EPITELIAIS |
| 1138/1644 | US=36-C / Biol/MOL Abbas AK, Lichtman AH, Pillai S. Introduction to the immune system: cells and tissues of the adaptive immune system. In: Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. 6 ed. Philadelphia: Saunders, 2007. p. 47-71. ISBN 978-1-4160-3122-2. CELULAS E TECIDOS DO SISTEMA IMUNE ADAPTATIVO; LINFOCITOS; CELULAS APRESENTADORAS DE ANTIGENOS; FUNCOES DOS TECIDOS LINFOIDES |
| 1139/1644 | US=36-C / Biol/MOL Abbas AK, Lichtman AH, Pillai S. Recognition of antigens: antibodies and antigens. In: Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. 6 ed. Philadelphia: Saunders, 2007. p. 75-96. ISBN 978-1-4160-3122-2. RECONHECIMENTO DE ANTIGENIOS; ANTICORPOS; ANTIGENIOS; ESTRUTURA MOLECULAR DE ANTICORPOS; LIGACAO DE ANTICORPOS DE ANTIGENIOS; MOLECULAS DE ANTICORPOS |
| 1140/1644 | US=36-C / Biol/MOL Abbas AK, Lichtman AH, Pillai S. Recognition of antigens: the major histocompatibility complex. In: Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. 6 ed. Philadelphia: Saunders, 2007. p. 97-111. ISBN 978-1-4160-3122-2. HISTOCOMPATIBILIDADE; MHC; RESPOSTA IMUNE; ESTRUTURA DAS MOLECULAS DE MHC; LIGACAO DE PEPTIDOS. MOLECULAS DE MHC; GENOMICA DO MHC |